UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Pharmacokinetics and Pharmacodynamics of Subcutaneous Recombinant Parathyroid Hormone (1–84) in Patients With Hypoparathyroidism: An Open-Label, Single-Dose, Phase I Study

Clinical therapeutics, 2014-05, Vol.36 (5), p.722-736

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon-Like Peptide-2 (GLP-2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

Journal of clinical pharmacology, 2008-11, Vol.48 (11), p.1289-1299

2008

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease

Journal of clinical pharmacology, 2010-01, Vol.50 (1), p.36-49

2010

Link zum Volltext

Verfügbarkeit prüfen

Utility of a population pharmacokinetic meta analysis during the approval process of teduglutide for the treatment of short bowel syndrome

International journal of clinical pharmacology and therapeutics, 2014-12, Vol.52 (12), p.1045

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Safety Profile of a Range of Teduglutide Doses Given for Eight Days in Healthy Volunteers: 258

The American journal of gastroenterology, 2007-09, Vol.102, p.S211

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Teduglutide in Parenteral Nutrition (PN)-Dependent SBS Subjects: Update of a Current Multinational Trial: 919

The American journal of gastroenterology, 2007-09, Vol.102, p.S456

2007

Link zum Volltext

Verfügbarkeit prüfen

757 Teduglutide, a Glucagon-Like Peptide-2 (GLP-2) Analog, Improves Fluid Balance in Short Bowel Syndrome (SBS) Patients Depending On Parenteral Support (PN)

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-110-A-111

2008

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's disease

Journal of clinical pharmacology, 2010-01, Vol.50 (1), p.36-49

2010

Link zum Volltext

Verfügbarkeit prüfen

Studies on arachidonate metabolism in rat liver and Morris hepatomas

Cyran, Jane Anne

1988

Link zum Volltext

Verfügbarkeit prüfen

Light-chain binding sites on renal brush-border membranes

American journal of physiology. Renal, fluid and electrolyte physiology, 1990-05, Vol.258 (5), p.1259

1990

Link zum Volltext

Verfügbarkeit prüfen

Experimental and theoretical evidence for bilayer-by-bilayer surface melting of crystalline ice

Proceedings of the National Academy of Sciences - PNAS, 2017-01, Vol.114 (2), p.227-232

2017

Link zum Volltext

Verfügbarkeit prüfen

Prostaglandin biosynthetic capacity of hepatomas with different growth rates

International journal of biochemistry, 1989, Vol.21 (4), p.445-451

1989

Link zum Volltext

Verfügbarkeit prüfen

Experimental and theoretical evidence for bilayer-bybilayer surface melting of crystalline ice

Proceedings of the National Academy of Sciences - PNAS, 2017-01, Vol.114 (2), p.227-232

2017

Link zum Volltext

Verfügbarkeit prüfen

Functional outcome after the Fontan operation: Factors influencing late morbidity

The Journal of thoracic and cardiovascular surgery, 1997-09, Vol.114 (3), p.392-403

1997

Link zum Volltext

Verfügbarkeit prüfen

Open Source Health Intelligence (OSHINT) for Foodborne Illness Event Characterization

Online journal of public health informatics, 2013-04, Vol.5 (1)

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(14)
Dissertationen
(1)

Sprache

Englisch
(15)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and Pharmacodynamics of Subcutaneous Recombinant Parathyroid Hormone (1–84) in Patients With Hypoparathyroidism: An Open-Label, Single-Dose, Phase I Study

Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon-Like Peptide-2 (GLP-2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease

Utility of a population pharmacokinetic meta analysis during the approval process of teduglutide for the treatment of short bowel syndrome

Pharmacokinetics and Safety Profile of a Range of Teduglutide Doses Given for Eight Days in Healthy Volunteers: 258

Efficacy and Safety of Teduglutide in Parenteral Nutrition (PN)-Dependent SBS Subjects: Update of a Current Multinational Trial: 919

757 Teduglutide, a Glucagon-Like Peptide-2 (GLP-2) Analog, Improves Fluid Balance in Short Bowel Syndrome (SBS) Patients Depending On Parenteral Support (PN)

Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's disease

Studies on arachidonate metabolism in rat liver and Morris hepatomas

Light-chain binding sites on renal brush-border membranes

Experimental and theoretical evidence for bilayer-by-bilayer surface melting of crystalline ice

Prostaglandin biosynthetic capacity of hepatomas with different growth rates

Experimental and theoretical evidence for bilayer-bybilayer surface melting of crystalline ice

Functional outcome after the Fontan operation: Factors influencing late morbidity

Open Source Health Intelligence (OSHINT) for Foodborne Illness Event Characterization

Suchergebnisse filtern